Improvement of wasting by treatment with a humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody, MRA in multicentric Castleman's disease. A phase II clinical trial of 28 patients.

被引：0

|

作者：

Nishimoto, N ^{[1
]}

Kanakura, Y ^{[1
]}

Aozasa, K ^{[1
]}

Johkoh, T ^{[1
]}

Nakano, N ^{[1
]}

Nakamura, M ^{[1
]}

Ikeda, Y ^{[1
]}

Sasaki, T ^{[1
]}

Nishioka, K ^{[1
]}

Hara, M ^{[1
]}

Taguchi, H ^{[1
]}

Kimura, Y ^{[1
]}

Kato, Y ^{[1
]}

Kishimoto, T ^{[1
]}

Yoshizaki, K ^{[1
]}

机构：

[1] Osaka Univ, Sch Hlth & Sport Sci, Dept Med Sci 1, Osaka, Japan

来源：

BLOOD | 2002年 / 100卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

760

引用

下载

收藏

页码：202A / 203A

页数：2

相关论文

共 43 条

[41] Long-Term Efficacy and Safety Results of a Global Phase 3 Trial of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment
Thorne, Carter
Takeuchi, Tsutomu
Karpouzas, George
Sheng, Shihong
Kurrasch, Regina
Fei, Kaiyin
Hsu, Benjamin
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[42] Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
Dorff, Tanya B.
Goldman, Bryan
Pinski, Jacek K.
Mack, Philip C.
Lara, Primo N., Jr.
Van Veldhuizen, Peter J., Jr.
Quinn, David I.
Vogelzang, Nicholas J.
Thompson, Ian M., Jr.
Hussain, Maha H. A.
CLINICAL CANCER RESEARCH, 2010, 16 (11) : 3028 - 3034
[43] Long-Term Effect of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, on Radiographic Progression in Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of a Global Phase 3 Trial
Karpouzas, George
Takeuchi, Tsutomu
Thorne, Carter
Sheng, Shihong
Kurrasch, Regina
Fei, Kaiyin
Hsu, Benjamin
ARTHRITIS & RHEUMATOLOGY, 2017, 69

← 1 2 3 4 5 →